STK40 anticorps (Middle Region) (FITC)
Aperçu rapide pour STK40 anticorps (Middle Region) (FITC) (ABIN8036143)
Antigène
Voir toutes STK40 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Fonction
- Anti-STK40 Antibody FITC Conjugated
-
Réactivité croisée (Details)
- No cross-reactivity with other proteins
-
Purification
- Immunogen affinity purified.
-
Immunogène
- A synthetic peptide corresponding to a sequence in the middle region of human STK40.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4.
-
Stock
- -20 °C
-
Stockage commentaire
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Date de péremption
- 12 months
-
-
- STK40 (serine/threonine Kinase 40 (STK40))
-
Autre désignation
- STK40
-
Sujet
-
Background: Predicted to enable ATP binding activity, protein serine kinase activity, and protein serine/threonine kinase activity. Predicted to be involved in regulation of MAPK cascade. Predicted to act upstream of or within several processes, including glycogen metabolic process, lung development, and respiratory system process. Located in cytosol and nucleoplasm.
Gene Full Name: serine/threonine kinase 40
-
ID gène
- 83931
-
UniProt
- Q8N2I9
Antigène
-